Altered angiogenesis has been implicated in the pathogenesis of various pregnancy complications, particularly preeclampsia. At present, there is a lack of data on the possible role of angiogenesis and its molecular mechanism in preterm pregnancy. We have previously reported reduced placental global DNA methylation levels in preterm pregnancy. Now, we have extended the study to examine plasma levels of angiogenic factors from maternal and cord blood and correlate them with placental promoter CpG methylation and messenger RNA expression of these angiogenic genes in preterm pregnancies.
Methods:
We recruited 99 women delivering at term and 90 women delivering preterm. Plasma levels of angiogenic factors, vascular endothelial growth factor (VEGF), placental growth factor (PlGF), fms-related tyrosine kinase 1 (FLT-1), and kinase insert domain receptor (KDR) were analyzed by enzyme-linked immunosorbent assay. Expression levels and promoter CpG methylation of angiogenic genes in placentae were determined by quantitative real-time polymerase chain reaction and by the Sequenom EpiTYPER technology, respectively.
Results:
Maternal VEGF and PlGF levels (P < .01 for both) were lower but soluble FLT-1 (sFLT-1) levels and sFLT-1–PlGF ratio (P < .05 for both) were higher in the preterm group. Placental VEGF expression (P < .05) was lower, and CpG site 14 in the VEGF promoter was hypermethylated (P < .05) in the preterm group. The KDR expression (P < .05) was higher in women delivering preterm.
Conclusions:
Our study provides first evidence of differential placental CpG methylation patterns and expression of VEGF, FLT-1, and KDR genes in women delivering preterm. This may explain the possible mechanism for angiogenic imbalance in the pathophysiology of preterm pregnancy.
DemirRYabaAHuppertzB. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation. Acta Histochem. 2010;112(3):203–214.
2.
FerraraNGerberHPLeCouterJ. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669–676.
3.
HeYSmithSKDayKAClarkDELicenceDRCharnock-JonesDS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol. 1999;13(4):537–545.
4.
EbosJMBocciGManS. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res. 2004;2(6):315–326.
5.
MunautCLorquetSPequeuxC. Differential expression of VEGFR-2 and its soluble form in preeclampsia. PLoS One. 2012;7(3):e33475.
6.
BergersGBenjaminLE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3(6):401–410.
7.
RomeroRNienJKEspinozaJ. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9–23.
8.
KulkarniAVMehendaleSSYadavHRKilariASTaralekarVSJoshiSR. Circulating angiogenic factors and their association with birth outcomes in preeclampsia. Hypertens Res. 2010;33(6):561–567.
9.
HarrisLK. IFPA Gabor Than Award lecture: Transformation of the spiral arteries in human pregnancy: key events in the remodelling timeline. Placenta. 2011;32(suppl 2):S154–S158.
10.
KimYMChaiworapongsaTGomezR. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol. 2002;187(5):1137–1142.
11.
KimYMBujoldEChaiworapongsaT. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2003;189(4):1063–1069.
12.
AmbroseJABaruaRS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–1737.
13.
ChaiworapongsaTRomeroRTarcaA. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med. 2009;22(12):1122–1139.
14.
SertTKırzıoğluFYFentoğluOAylakFMunganT. Serum placental growth factor, vascular endothelial growth factor, soluble vascular endothelial growth factor receptor-1 and -2 levels in periodontal disease, and adverse pregnancy outcomes. J Periodontol. 2011;82(12):1735–1748.
15.
AndraweeraPHDekkerGALaurenceJARobertsCT. Placental expression of VEGF family mRNA in adverse pregnancy outcomes. Placenta. 2012;33(6):467–472.
16.
DaneshmandSSChmaitRHMooreTRBogicL. Preterm premature rupture of membranes: vascular endothelial growth factor and its association with histologic chorioamnionitis. Am J Obstet Gynecol. 2002;187(5):1131–1136.
17.
MarvinKWKeelanJAEykholtRLSatoTAMitchellMD. Expression of angiogenic and neurotrophic factors in the human amnion and choriodecidua. Am J Obstet Gynecol. 2002;187(3):728–734.
JoshiSRMehendaleSSDangatKDKilariASYadavHRTaralekarVS. High maternal plasma antioxidant concentrations associated with preterm delivery. Ann Nutr Metab. 2008;53(3-4):276–282.
20.
KilariASMehendaleSSDangatKD. Long chain polyunsaturated fatty acids in mothers of preterm babies. J Perinat Med. 2010;38(6):659–664.
21.
DhobaleMVWadhwaniNMehendaleSSPisalHRJoshiSR. Reduced levels of placental long chain polyunsaturated fatty acids in preterm deliveries. Prostaglandins Leukot Essent Fatty Acids. 2011;85(3-4):149–153.
22.
DhobaleMChavanPKulkarniAMehendaleSPisalHJoshiS. Reduced folate, increased vitamin B12 and homocysteine concentrations in women delivering preterm. Ann Nutr Metab. 2012;61(1):7–14.
23.
DhobaleMMehendaleSPisalHNimbargiVJoshiS. Reduced maternal and cord nerve growth factor levels in preterm deliveries. Int J Dev Neurosci. 2012;30(2):99–103.
24.
KulkarniADangatKKaleASablePChavan-GautamPJoshiS. Effects of altered maternal folic acid, vitamin B12 and docosahexaenoic acid on placental global DNA methylation patterns in Wistar rats. PLoS One. 2011;6(3):e17706.
25.
GiaccoFBrownleeM. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–1070.
26.
KaleANaphadeNSapkaleS. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res. 2010;175(1-2):47–53.
27.
DavisCDUthusEO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood). 2004;229(10):988–995.
28.
RobertsCT. IFPA Award in placentology lecture: complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health. Placenta. 2010;31 suppl:S47–S53.
29.
Chavan-GautamPSundraniDPisalHNimbargiVMehendaleSJoshiS. Gestation-dependent changes in human placental global DNA methylation levels. Mol Reprod Dev. 2011;78(3):150.
30.
SundraniDPReddyUSJoshiAA. Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia. Clin Epigenetics. 2013;5(1):6.
31.
BarutFBarutAGunBD. Intrauterine growth restriction and placental angiogenesis. Diagn Pathol. 2010;5:24.
32.
HelskeSVuorelaPCarpénOHornigCWeichHHalmesmäkiE. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod. 2001;7(2):205–210.
33.
SavasanZARomeroRChaiworapongsaT. Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2010;23(8):828–841.
34.
MorganTKTolosaJEMeleL. Placental villous hypermaturation is associated with idiopathic preterm birth. J Matern Fetal Neonatal Med. 2013;26(7):647–653.
35.
NovakovicBYuenRKGordonL. Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors. BMC Genomics. 2011;12:529.
36.
YuenRKPenaherreraMSvon DadelszenPMcFaddenDERobinsonWP. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet. 2010;18(9):1006–1012.
37.
JośkoJMazurekM. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit. 2004;10(4):RA89–RA98.
38.
FarréDRosetRHuertaM. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003;31(13):3651–3653.
39.
MesseguerXEscuderoRFarréDNúñezOMartínezJAlbàMM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18(2):333–334.
40.
GibbsJRvan der BrugMPHernandezDG. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010;6(5):e1000952.
41.
MaunakeaAKNagarajanRPBilenkyM. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010;466(7303):253–257.
42.
ZhangDChengLBadnerJA. Genetic control of individual differences in gene-specific methylation in human brain. Am J Hum Genet. 2010;86(3):411–419.
43.
BrenetFMohMFunkP. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One. 2011;6(1):e14524.
44.
SundraniDKhotVPisalH. Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy. PLoS One. 2013;8(1):e54153.
45.
WeinbergerBAnwarMHegyiTHiattMKoonsAPanethN. Antecedents and neonatal consequences of low Apgar scores in preterm newborns: a population study. Arch Pediatr Adolesc Med. 2000;154(3):294–300.
